12th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

描述(由申请人提供)：美国心脏协会动脉硬化、血栓和血管生物学委员会(ATVB)举行一年一度的春季会议。ATVB 2010是该系列的第11次会议，将于2010年4月7日至10日在旧金山举行。ATVB会议的规模随着时间的推移而增加，ATVB2010有超过1000名注册人员，到会议时应该会超过1100名参与者。ATVB会议的总体目标是将致力于心血管疾病的基础、翻译和临床方面的初级和高级科学家聚集在一起，以便进行科学交流，并迅速传播与我们对心血管系统的生理学和病理生理学的理解相关的新发现。会议的具体目标是：1)促进在心血管疾病中具有重要意义的不同领域的研究人员之间交流科学信息和实验策略；2)确定和传播关于可以促进所有领域研究的新技术的信息；3)加强基础科学发现向翻译/临床前研究并最终应用于临床的转移；4)鼓励相关领域的研究人员结识并促进科学合作；以及5)为学生和研究员提供一个向知情的受众展示数据的场所，以期鼓励他们在该领域的发展和保留。会议旨在通过提供一个论坛，展示约500张个人海报或口头陈述，从而实现这些目标。将早期职业调查人员整合和教育到这些讨论中，这是我们的第五个目标，是该项目特别重要的一部分。会议的规模足够小，使学生和研究员能够积极参与海报和口头会议，彼此之间以及与国内外知名科学家的互动，不仅来自他们的研究领域，而且来自动脉硬化、血栓形成和血管生物学的不同方面。这项申请特别要求提供资金，以便通过提供旅行奖励，使年轻调查人员参与和融入该领域的工作。已经建立了一个成功的制度，鼓励年轻的研究人员申请这些奖项，根据科学功绩评选最受欢迎的申请，并在会议上表彰获奖者。这项现有拨款的成功续期所提供的资金将支持从2011年到2016年的每一届ATVB年度会议的旅行奖，并将有助于确保ATVB会议将继续为早期研究人员提供一个平台，让他们成为科学界的参与者和贡献者。 公共卫生相关性：这一续订申请寻求支持青年研究人员参加美国心脏协会动脉硬化、血栓形成和血管生物学会议的年度会议。ATVB会议为早期研究人员提供了独特的机会，让他们与同行见面，展示他们的工作，并与不同学科的资深同事互动，这些学科将心血管疾病作为一个统一的主题。

DESCRIPTION (provided by applicant): The Council of Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) of the American Heart Association holds an annual Spring meeting. ATVB 2010 is the 11th meeting in the series and will be held in San Francisco, April 7-10, 2010. The size of the ATVB meeting has increased over time and ATVB2010 has over 1000 registrants and should exceed 1100 participants by the time of the meeting. The overall goal of the ATVB meetings is bring together junior and senior scientists working on basic, translational and clinical aspects of cardiovascular disease for the purpose of scientific interchange and rapid dissemination of new discoveries that are relevant to our understanding of the physiology and pathophysiology of the cardiovascular system. The specific aims of the conference are: 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas of great importance in cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) to encourage investigators in related fields to become acquainted and to promote scientific collaborations; and 5) to provide a venue for students and fellows to present data to an informed audience with an eye toward encouraging their development and retention in the field. The meeting is designed to meet these aims by providing a forum for presentation of about 500 individual poster or oral presentations. Integration and education of early career investigators into these discussions, our fifth aim, is a particularly important part of the program. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions and to interact with one another and with well known national and international scientists not only from their area of research but also from the diverse aspects of arteriosclerosis, thrombosis and vascular biology. This application specifically requests funds for its effort to engage and integrate young investigators into the field through its provision of Travel Awards. A successful system is in place to encourage young investigators to apply for these awards, to judge the top applications based on scientific merit, and to recognize the awardees at the meeting. The funds provided by a successful renewal of this existing grant would support the Travel Awards to each of the annual ATVB meetings from 2011 through 2016 and will help to assure that the ATVB meeting will continue to provide a platform for early stage investigators to become engaged and contributing members of the scientific community. PUBLIC HEALTH RELEVANCE: This renewal application seeks support for Travel Awards for Young Investigators to attend the annual meetings of the Arteriosclerosis, Thrombosis and Vascular Biology Meetings of the American Heart Association. The ATVB meetings provide unique opportunities for early stage investigators to meet peers, present their work, and interact with senior colleagues across distinct disciplines that have an interest in cardiovascular disease as a unifying theme.